Astec Lifesciences
add_icon

Astec Lifesciences

635.95
-21.90
(-3.33%)
Market Cap
1,417.00 Cr
PE Ratio
-16.48
Volume
69,145.00
Day High - Low
646.90 - 630.30
52W High-Low
990.82 - 554.00
ann
There are 2 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,417.00 Cr
EPS
-68.71
PE Ratio
-16.48
PB Ratio
3.55
Book Value
185.45
EBITDA
-60.60
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
-57.32
Debt to Equity
1.74
Forecast For
Actual

Company News

View All News
Caret
positive
Astec Lifesciences reported reduced consolidated net loss of ₹157M in Q3 compared to ₹404M loss in previous year, while revenue grew 33% to ₹1.25B from ₹939M year-on-year.
neutral
ASTEC Lifesciences announces the resignation of Chief Financial Officer Mugdha Amol Khare from her position at the agrochemical company.
positive
Astec Lifesciences Limited has appointed Mr. Milind Bhangaonkar as General Manager-Operations (Site Head) and Senior Management Personnel effective December 15, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
741.30
#1 62,515.22
31.49
#1 47,123.00
8.13
820
-42.56
50.36
3,129.30
47,477.15
31.50
8,322.00
5.70
#1 1,660
-19.46
42.63
410.35
20,482.45
39.37
3,268.60
11.19
506
-13.27
40.02
4,489.90
20,178.55
32.96
5,593.10
7.89
568
12.03
55.53
1,192.30
10,756.99
18.57
4,379.40
#1 35.89
304
#1 366.56
77.28
270.65
5,263.30
31.33
2,631.40
6.54
164
-274.07
54.27
1,051.00
4,737.73
#1 16.24
2,071.30
15.49
297
27.97
37.01
136.13
3,185.62
-74.00
1,242.60
-30.48
-92
71.82
36.11
1,828.60
3,039.33
23.24
1,199.00
12.53
141
-13.08
41.37
227.61
2,951.40
240.32
449.80
9.63
14
1.85
56.72
Growth Rate
Revenue Growth
-16.58 %
Net Income Growth
187.21 %
Cash Flow Change
-182.19 %
ROE
351.69 %
ROCE
219.94 %
EBITDA Margin (Avg.)
26,000.00 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
99
60
68
31
85
71
86
62
87
68
98
80
130
66
115
123
140
78
142
129
186
113
157
119
174
130
104
175
279
187
204
121
130
145
112
52
156
70
101
96
120
92
75
126
Expenses
91
47
62
39
69
59
64
53
76
60
81
61
97
56
89
98
111
71
125
104
138
84
126
100
134
104
82
131
207
159
167
105
122
140
114
69
141
116
118
100
114
102
80
123
EBITDA
8
12
6
-8
16
12
22
10
11
9
16
19
33
9
25
24
29
7
17
25
48
30
31
19
40
26
22
45
72
28
37
16
8
5
-2
-17
15
-45
-18
-4
6
-11
-6
3
Operating Profit %
2 %
20 %
7 %
-26 %
12 %
16 %
25 %
14 %
12 %
9 %
15 %
18 %
24 %
13 %
21 %
18 %
17 %
8 %
11 %
17 %
24 %
25 %
19 %
13 %
22 %
19 %
21 %
25 %
24 %
14 %
17 %
10 %
4 %
2 %
-3 %
-36 %
8 %
-67 %
-20 %
-6 %
5 %
-12 %
-9 %
2 %
Depreciation
1
3
3
2
3
3
4
2
4
4
4
4
4
4
5
5
6
6
6
6
6
6
6
7
7
7
8
9
11
9
8
9
8
9
9
9
9
9
12
11
12
12
10
11
Interest
3
3
3
3
3
3
3
3
3
3
3
3
2
3
3
4
3
4
4
3
2
2
1
1
1
2
2
3
3
4
5
6
6
7
6
6
7
7
9
10
10
11
8
7
Profit Before Tax
4
7
2
-11
15
5
15
5
4
6
10
13
27
3
18
15
20
-2
8
16
40
22
24
11
32
17
12
33
58
15
25
1
-6
-11
-18
-32
-1
-62
-39
-25
-16
-33
-24
-16
Tax
1
2
-0
-3
9
1
4
4
1
2
3
6
10
1
6
5
8
-1
3
3
9
6
6
4
8
5
3
9
15
4
6
0
-1
-3
-4
-8
0
-22
0
15
0
0
0
0
Net Profit
3
5
2
-8
6
4
11
1
4
4
7
7
17
2
12
10
13
-1
5
12
31
16
18
7
24
13
9
25
43
11
18
1
-5
-8
-13
-24
-1
-40
-39
-40
-16
-33
-24
-16
EPS in ₹
1.74
2.66
1.05
-4.03
2.88
1.93
5.74
0.36
1.77
2.04
3.44
3.67
8.78
0.08
5.92
5.10
6.50
-0.57
2.70
6.22
15.94
8.27
9.12
3.61
12.24
6.63
4.63
12.63
21.97
5.82
9.34
0.43
-2.54
-4.18
-6.85
-12.41
-0.50
-20.26
-19.66
-20.59
-8.20
-16.85
-11.35
-7.04

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
362
330
334
413
461
572
678
897
979
975
881
Fixed Assets
133
95
103
115
167
194
213
340
319
386
499
Current Assets
204
191
198
232
249
332
330
516
499
399
341
Capital Work in Progress
12
20
8
42
19
24
116
23
127
165
21
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
217
215
223
256
275
354
349
534
534
424
361
Total Liabilities
362
330
334
413
461
572
678
897
979
975
881
Current Liabilities
178
203
194
238
249
318
322
491
526
397
366
Non Current Liabilities
49
9
2
5
10
7
46
10
34
208
281
Total Equity
135
118
138
170
203
247
309
397
420
370
235
Reserve & Surplus
116
99
119
150
183
227
290
377
400
350
215
Share Capital
20
20
20
20
20
20
20
20
20
20
20

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
2
1
-3
-0
0
0
0
-0
0
0
Investing Activities
-19
-17
-18
-49
-53
-74
-73
-104
-113
-135
-15
Operating Activities
8
-13
19
65
15
168
-8
24
75
10
-8
Financing Activities
12
31
-1
-18
37
-95
81
81
38
125
24

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sept 2025
Dec 2025
Promoter
65.23 %
65.20 %
65.20 %
65.19 %
65.29 %
65.29 %
66.77 %
66.77 %
66.77 %
66.76 %
66.75 %
66.75 %
66.75 %
66.75 %
66.75 %
66.75 %
70.87 %
70.87 %
72.42 %
72.42 %
71.97 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.28 %
1.25 %
1.03 %
0.53 %
1.20 %
0.25 %
0.02 %
0.02 %
0.00 %
0.04 %
DIIs
9.76 %
9.58 %
11.36 %
11.69 %
11.16 %
10.24 %
9.83 %
9.56 %
9.58 %
10.15 %
9.15 %
9.74 %
7.88 %
3.38 %
4.51 %
5.41 %
4.34 %
4.26 %
4.01 %
4.01 %
3.17 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.06 %
19.33 %
18.06 %
17.41 %
17.46 %
18.26 %
18.02 %
17.86 %
16.81 %
17.75 %
17.91 %
18.19 %
19.62 %
22.52 %
21.95 %
20.71 %
19.62 %
19.98 %
18.96 %
19.32 %
20.87 %
Others
5.94 %
5.89 %
5.38 %
5.71 %
6.09 %
6.21 %
5.38 %
5.82 %
6.85 %
5.34 %
6.19 %
4.03 %
4.49 %
6.33 %
6.26 %
5.93 %
4.91 %
4.87 %
4.59 %
4.25 %
3.95 %
No of Share Holders
0
19,872
22,817
21,073
19,002
16,951
17,433
17,632
17,809
18,703
18,722
19,244
19,848
19,955
19,727
19,057
18,689
18,549
18,889
18,276
22,293

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1.5 1.5 1.5 1.5 1.5 1.5 1.5 0.00 0.00 0.00
Dividend Yield (%) 0.26 0.28 0.39 0.15 0.09 0.11 0.14 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Jul 2021 DIVIDEND Dividend
₹ 1.50 /share
22 Jul 2021 1,153.34 1,373.99
21 Jul 2022 DIVIDEND Dividend
₹ 1.50 /share
19 Jul 2022 1,815.32 2,053.13
22 Jul 2023 DIVIDEND Dividend
₹ 1.50 /share
21 Jul 2023 1,320.32 1,281.21
27 Jul 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Jul 2023 1,320.32 1,238.53
29 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Jul 2024 1,274.65 1,273.21
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Oct 2024 1,088.08 1,064.11
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 1,008.69 955.39
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Apr 2025 699.75 757.08
04 Jul 2025 RIGHTS Rights
1:7
04 Jul 2025 929.44 940.36
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2025 897.60 900.15
28 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Jul 2025 757.08 900.15
29 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2025 748.10 683.85
30 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2026 660.85 575.40

Announcements

Reply On Significant Increase In The Volume Of Security22 hrs ago
Clarification sought from Astec Lifesciences Ltd1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication7 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release7 days ago
Appointment Of Chief Financial Officer7 days ago
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)7 days ago
Outcome Of Board Meeting7 days ago
Board Meeting Outcome for Outcome Of Board Meeting7 days ago
Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December 2025 After These Results Are Reviewed By The Audit Committee.Jan 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Closure of Trading WindowDec 24, 2025
Intimation Of Appointment Of Senior Management PersonnelDec 15, 2025
Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 07, 2025
Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 29, 2025
Statement Of Deviation And Variation For The Quarter And Half- Year Ended September 30 2025Oct 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 29, 2025
Financial Result For The Quarter And Half-Year Ended September 30 2025.Oct 29, 2025
Board Meeting Outcome for Revised OutcomeOct 29, 2025
Financial Result For The Quarter And Half-Year Ended September 30 2025.Oct 29, 2025
Board Meeting Outcome for Outcome Of Board MeetingOct 29, 2025
Change In Senior Management PersonnelOct 24, 2025
Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 After These Results Are Reviewed By The Audit CommitteeOct 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 06, 2025
IntimationOct 03, 2025
Intimation For Seeking Shareholders Approval For Material Related Party TransactionsOct 03, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 03, 2025
IntimationOct 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateOct 03, 2025
Closure of Trading WindowSep 26, 2025
Appointment Of Mr. Sunil Kataria And Cessation Of Mr. Balram Singh Yadav.Aug 29, 2025
Appointment Of Mr. Sunil Kataria And Cessation Of Mr. Balram Singh Yadav.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 29, 2025
Intimation Of Receiving Show Cause Cum Demand NoticeAug 01, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesJul 29, 2025
Intimation Of Appointment Of Secretarial AuditorsJul 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 28, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2025
QUATERLY FINANCIAL RESULTSJul 28, 2025
Board Meeting Outcome for Outcome Of Board MeetingJul 28, 2025

Technical Indicators

RSI(14)
Neutral
56.47
ATR(14)
Volatile
37.13
STOCH(9,6)
Neutral
46.59
STOCH RSI(14)
Overbought
94.83
MACD(12,26)
Bullish
8.03
ADX(14)
Strong Trend
27.41
UO(9)
Bearish
44.57
ROC(12)
Uptrend And Accelerating
6.38
WillR(14)
Overbought
-18.87